Header

UZH-Logo

Maintenance Infos

What can we learn from epigenetics in the year 2009?


Jüngel, A; Ospelt, C; Gay, S (2010). What can we learn from epigenetics in the year 2009? Current Opinion in Rheumatology, 22(3):284-292.

Abstract

PURPOSE OF REVIEW: Rheumatoid arthritis (RA) is a systemic, autoimmune disease resulting in the destruction of affected joints. Even though current therapies with biologics such as tumor necrosis factor-alpha blockers yield significant improvement for the patients, the disease is not curable yet. Therefore, we need novel strategies for better therapies. RECENT FINDINGS: The growing knowledge of epigenetics might give us new insights into the pathogenesis of autoimmune diseases. In the last year, several new findings about epigenetic modifications of gene expression were reported in different arthritides. These modifications describe changes in the expression of DNA that result from methylation, posttranslational modifications of the histone proteins, including acetylation/deacetylation, sumoylation, methylation and microRNAs. Most interestingly, these modifications seem to act in concert and are associated with the circadian metabolic rhythm of cells. SUMMARY: This review summarizes reports from the last year about epigenetic modifications of gene expression via acetylation/deacetylation, including sirtuins, sumoylation, methylation, microRNAs in all in rheumatoid arthritis and other arthritides, providing potential strategies for better therapies and encourages the development of specific epigenetic drugs.

Abstract

PURPOSE OF REVIEW: Rheumatoid arthritis (RA) is a systemic, autoimmune disease resulting in the destruction of affected joints. Even though current therapies with biologics such as tumor necrosis factor-alpha blockers yield significant improvement for the patients, the disease is not curable yet. Therefore, we need novel strategies for better therapies. RECENT FINDINGS: The growing knowledge of epigenetics might give us new insights into the pathogenesis of autoimmune diseases. In the last year, several new findings about epigenetic modifications of gene expression were reported in different arthritides. These modifications describe changes in the expression of DNA that result from methylation, posttranslational modifications of the histone proteins, including acetylation/deacetylation, sumoylation, methylation and microRNAs. Most interestingly, these modifications seem to act in concert and are associated with the circadian metabolic rhythm of cells. SUMMARY: This review summarizes reports from the last year about epigenetic modifications of gene expression via acetylation/deacetylation, including sirtuins, sumoylation, methylation, microRNAs in all in rheumatoid arthritis and other arthritides, providing potential strategies for better therapies and encourages the development of specific epigenetic drugs.

Statistics

Citations

5 citations in Web of Science®
23 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

96 downloads since deposited on 24 Nov 2010
19 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2010
Deposited On:24 Nov 2010 16:26
Last Modified:21 Nov 2017 15:00
Publisher:Lippincott Wiliams & Wilkins
ISSN:1040-8711
Additional Information:This a non-final version of an article published in final form in Jüngel, A; Ospelt, C; Gay, S (2010). What can we learn from epigenetics in the year 2009? Current Opinion in Rheumatology, 22(3):284-292.
Publisher DOI:https://doi.org/10.1097/BOR.0b013e3283389641
PubMed ID:20305560

Download

Download PDF  'What can we learn from epigenetics in the year 2009?'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 121kB
View at publisher